ADARB2 and astrocytoma (excluding glioblastoma): Oakes et al. reported that overexpression of ADAR3 inhibited RNA editing at the Q607R site of GRIA2 in astrocyte and astrocytoma cell lines [14], which indicted the competitive inhibition of ADAR2 with ADAR3 on this site.